- Home
- STBX vs LVTX Comparison
STBX vs LVTX Comparison
Compare STBX & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STBX
- LVTX
- Stock Information
- Founded
- STBX 2019
- LVTX 2016
- Country
- STBX Malaysia
- LVTX Netherlands
- Employees
- STBX N/A
- LVTX N/A
- Industry
- STBX Advertising
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- STBX Consumer Discretionary
- LVTX Health Care
- Exchange
- STBX Nasdaq
- LVTX Nasdaq
- Market Cap
- STBX 51.1M
- LVTX 43.9M
- IPO Year
- STBX 2022
- LVTX 2021
- Fundamental
- Price
- STBX $0.12
- LVTX $1.65
- Analyst Decision
- STBX
- LVTX Strong Buy
- Analyst Count
- STBX 0
- LVTX 2
- Target Price
- STBX N/A
- LVTX $6.00
- AVG Volume (30 Days)
- STBX 96.3K
- LVTX 34.6K
- Earning Date
- STBX 10-22-2024
- LVTX 11-14-2024
- Dividend Yield
- STBX N/A
- LVTX N/A
- EPS Growth
- STBX N/A
- LVTX N/A
- EPS
- STBX N/A
- LVTX N/A
- Revenue
- STBX $12,213,183.00
- LVTX $7,398,000.00
- Revenue This Year
- STBX N/A
- LVTX N/A
- Revenue Next Year
- STBX N/A
- LVTX N/A
- P/E Ratio
- STBX N/A
- LVTX N/A
- Revenue Growth
- STBX 48.08
- LVTX N/A
- 52 Week Low
- STBX $0.10
- LVTX $1.13
- 52 Week High
- STBX $1.06
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- STBX 37.30
- LVTX 46.15
- Support Level
- STBX $0.11
- LVTX $1.59
- Resistance Level
- STBX $0.13
- LVTX $1.75
- Average True Range (ATR)
- STBX 0.01
- LVTX 0.08
- MACD
- STBX 0.00
- LVTX 0.00
- Stochastic Oscillator
- STBX 41.38
- LVTX 41.18
About STBX Starbox Group Holdings Ltd.
Starbox Group Holdings Ltd engages in developing cash rebate, digital advertising, and payment solution business ecosystem targeting micro, small, and medium enterprises. Through the firm's subsidiaries in Malaysia, it connects retail merchants with retail shoppers to facilitate transactions through cash rebates offered by retail merchants, provide digital advertising services to advertisers, and provide payment solution services to merchants. Substantially all of its current operations are located in Malaysia. It operates in five segments include Cash rebate, payment solution, and media booking, Advertising services, Software licensing and Production services, Marketing and Promotional campaign services segment.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.